Aditxt, Inc. (ADTX)
NASDAQ: ADTX · Real-Time Price · USD
0.530
-0.025 (-4.52%)
At close: Nov 1, 2024, 4:00 PM
0.529
-0.001 (-0.17%)
After-hours: Nov 1, 2024, 7:59 PM EDT
Aditxt Employees
Aditxt had 47 employees as of December 31, 2023. The number of employees decreased by 14 or -22.95% compared to the previous year.
Employees
47
Change (1Y)
-14
Growth (1Y)
-22.95%
Revenue / Employee
$7,016
Profits / Employee
-$921,560
Market Cap
55.92K
Employees Chart
ADTX News
- 1 day ago - Aditxt's Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission - Business Wire
- 2 days ago - Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time - Business Wire
- 3 days ago - Sylvia Hermina Joins Aditxt's Board of Directors, Elevating Leadership with Broader Perspectives - Business Wire
- 4 days ago - Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem - Business Wire
- 11 days ago - Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time - Business Wire
- 22 days ago - Aditxt's Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili's Shareholder Approval - Business Wire
- 23 days ago - Aditxt To Host Stakeholder Update and Q&A Session on Friday, October 11, 2024, at 11:30 AM Eastern Daylight Time - Business Wire
- 24 days ago - Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem - Business Wire